NEW YORK (GenomeWeb News) – Swiss analytical services company Biolytix has bought an Affymetrix GeneChip instrument and has signed a service provider agreement with Affymetrix UK, Biolytix said today.
The company plans to use the GeneChip platform to offer exon and tiling arrays and SNP genotyping and gene-mapping arrays that could be used in transcriptome mapping, gene regulation, genome-wide SNP mapping, and re-sequencing.
Financial terms of the agreement were not released.